Biopharmaceuticals
News Release - March 26, 2007
Bosentan -- Tracleer -- Receives Positive EU Opinion for Reduction of New Digital Ulcerations in Systemic Sclerosis Patients
Source: Actelion
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.